SARS CoV-2 Antibody Persistence During Induction Chemotherapy for Pediatric T-Cell Acute Lymphoblastic Leukemia. Pearce J, Friar S, Jigoulina G, Bate J, et al. J Pediatr Hematol Oncol 2021 Apr 26. pii: 00043426-900000000-96906.

Read + Share

Amedeo Smart

Independent Medical Education

Pearce J, Friar S, Jigoulina G, Bate J, et al. SARS CoV-2 Antibody Persistence During Induction Chemotherapy for Pediatric T-Cell Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol 2021 Apr 26. pii: 00043426-900000000-96906.
PMID: 33902067